Foundations of Psychedelic Psychotherapy
Foundations of Psychedelic Psychotherapy equips health pros with key knowledge & skills in emerging psychedelic therapies.
Provider
Details
Enrollment
Course Overview
Foundations of Psychedelic Psychotherapy is a 15-week course designed to equip health professionals with a comprehensive understanding of the emerging field of psychedelic psychotherapy. This course is poised at the forefront of mental health treatment, offering an in-depth exploration of MDMA and psilocybin therapies, both of which are expected to gain government regulation in the near future.
This program, hosted by the UHN Psychedelic Psychotherapy Research Group, provides trainees with a balanced blend of evidence-based knowledge, experiential learning, and teachings from multiple perspectives. The course places a strong emphasis on fostering a community of learners dedicated to shaping the future of psychedelic psychotherapy in Canada through an ethical and safe practice framework.
About the Provider
The Michener Institute, a clinical health sciences education affiliate of the University Health Network (UHN) in Toronto, offers a Foundations of Psychedelic Psychotherapy course for healthcare professionals seeking training in ketamine-assisted and psychedelic therapy modalities. As part of one of Canada's leading academic health science institutions, the program bridges clinical rigour with the emerging evidence base for psychedelic-assisted therapy.
View Michener profileCourse Details
- Price$4,500
- FormatLive Classes
- Lifecycle statusNo New Dates
- Skillsunderstanding psychedelic pharmacologyrecognizing non-ordinary statesethical practice considerationspatient screening and assessmentpatient preparation for psychedelic workguiding dosing sessions
- Categories
Related Courses
View all coursesCertificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
FDA On MDMA-Assisted Psychotherapy
By Integrative Mental Health University
This page discusses the FDA's rejection of MDMA-assisted psychotherapy and summarizes the rationale given for further research. It also reviews MDMA's history, reported therapeutic uses, and MAPS' response to the decision.
MAPS International MDMA-assisted Therapy Training Program
By Psychedelic Support
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.